Scleroderma and Your Feet: Managing Raynaud’s, Digital Ulcers, and Mobility

Quick answer: Scleroderma Feet Raynauds Digital Ulcers Mobility Care is a common foot/ankle topic that affects many patients. Effective treatment starts with a targeted diagnosis, conservative-first treatment, and escalation only when needed. We treat this regularly at our Howell and Bloomfield Township practices. Call (810) 206-1402.

If you have been diagnosed with scleroderma — or you suspect that you might have it — the feet are often where the disease shows up earliest and where the day-to-day suffering is greatest. Patients tell us, “I used to walk for miles, and now my toes turn white at the grocery store.” Or, “I have a small ulcer on my big toe that just won’t heal.” In our Howell and Bloomfield Hills clinics, we partner with rheumatology and vascular medicine to keep scleroderma feet walking, intact, and out of the operating room.

Scleroderma — technically systemic sclerosis — is a rare autoimmune connective tissue disease that affects roughly 240 per million adults in the United States. It hits women 4 to 5 times more often than men, usually starts between ages 30 and 50, and progresses unpredictably. The foot complications are not minor inconveniences. Digital ulcers occur in 30 to 50% of patients at some point, and a fingertip or toe ulcer can become limb-threatening within weeks if it goes unrecognized. This guide walks through every foot complication, the warning signs we never ignore, and the daily protocol that keeps these feet healthier.

What Is Scleroderma in the Feet?

Scleroderma in the feet is the local expression of a systemic disease that hardens skin and damages small blood vessels. The autoimmune process produces excess collagen and triggers progressive narrowing of the digital arteries that feed the toes. The result, over months to years, is some combination of cold, color-changing toes (Raynaud’s), painful ulcerations on tips and pressure points, calcium deposits under the skin, joint contractures, and reduced ankle and toe mobility. Limited cutaneous scleroderma (CREST) is the more common subtype, while diffuse cutaneous scleroderma progresses faster and tends to involve more internal organs.

In our clinic, we approach scleroderma feet with a single guiding principle: tissue is fragile and slow to heal, so prevention beats treatment every time. A small fissure on the heel of a non-scleroderma patient is a 3-day annoyance. The same fissure on a scleroderma patient with poor digital perfusion can take 3 months to close, become infected, and end up costing a digit. The whole protocol below exists to keep that small fissure from happening in the first place.

Raynaud’s Phenomenon (95% of Patients)

Raynaud’s phenomenon is the earliest and most common foot manifestation of scleroderma, present in roughly 95% of patients. It is the classic three-color sequence: white (vasoconstriction in response to cold or stress), then blue (deoxygenation), then red (reactive hyperemia on rewarming). Episodes can last minutes to hours and are triggered by cold air, cold water, walking into an air-conditioned store, or emotional stress. Patients describe burning, tingling, and aching as the toes rewarm. Repeated, severe Raynaud’s causes permanent damage to digital arteries and is the precursor to digital ulceration.

Management starts with strict cold avoidance: heated socks, glove liners, layered insulation, and never going outside in winter without insulated footwear. Stop smoking immediately — nicotine vasoconstricts and dramatically increases ulcer risk. Calcium-channel blockers (typically nifedipine 30–120 mg/day) are first-line pharmacologic therapy and reduce attack frequency by 30–50%. Severe disease may need PDE-5 inhibitors (sildenafil), endothelin-receptor antagonists (bosentan), or prostacyclin infusions (iloprost). Beta-blockers and amphetamine stimulants worsen Raynaud’s and should be reviewed with your rheumatologist.

Digital Ulcers (30–50% Lifetime Risk)

Digital ulcers are the most disabling foot complication of scleroderma. They form on toe tips from chronic ischemia, on dorsal interphalangeal joints from skin tension over flexed digits, and on bony pressure points from rigid skin over thin soft tissue. Roughly 30 to 50% of scleroderma patients develop digital ulcers in their lifetime, and many recur. Once a digital ulcer forms, healing time averages 6 to 12 weeks for uncomplicated lesions and 6 months or more for ischemic ulcers with calcinosis. Up to 5% of patients will require amputation of at least one digit.

Treatment is multifactorial. Wound care: nonadherent dressings (hydrogel, alginate, or silver-impregnated for infection), moist wound-healing principles, and absolute off-loading. Vascular support: optimize the underlying Raynaud’s medication, add an endothelin-receptor antagonist if recurrent (bosentan reduces new ulcers by 30–50%), consider prostacyclin infusions for severe ischemic ulcers. Infection control: any redness, drainage, increased pain, fever, or odor warrants same-day eval and culture. Pain control: scleroderma ulcer pain is severe and often disproportionate to ulcer size; standard analgesia plus gabapentinoids when neuropathic features dominate.

Calcinosis Cutis

Calcinosis cutis is the deposition of calcium salts in the skin and subcutaneous tissue. In scleroderma feet, it most commonly involves the toe pads, fingertip equivalents in toes, and pressure points along bony prominences. Patients often describe small white, gritty extrusions of chalky material that occasionally erupt through the skin. Calcinosis is painful, prone to ulceration, and a common nidus for chronic non-healing wounds. About 25 to 40% of patients with limited scleroderma (CREST) develop calcinosis, often after years of disease.

No medical therapy reliably dissolves calcinosis. Treatment is symptomatic: pressure relief with custom-padded orthotics, surgical curettage of localized painful nodules, and aggressive wound care for ulcerated lesions. Some centers use carbon dioxide laser or extracorporeal shockwave for selected cases. The mainstay in our practice is pressure off-loading with custom accommodative orthoses and shoe modifications — calcinosis nodules under metatarsal heads or on toe tips need plant-pad cutouts, soft inlays, and extra-depth shoes.

Skin Tightening & Sclerodactyly

Sclerodactyly — thickening and tightening of the skin over the digits — is a hallmark of scleroderma in both the hands and the feet. The skin loses elasticity, develops a shiny, waxy appearance, and traps the underlying joints in flexion. Over time, the toes lose their normal range of motion, the toe pulps thin, and the nails thicken or become abnormal in shape. Pressure on these stiffened toes and fragile skin causes ulceration over the dorsum of interphalangeal joints, which is why so many digital ulcers form there.

Daily moisturization is non-negotiable. We instruct patients to apply a thick, fragrance-free emollient (CeraVe, Eucerin, Aquaphor) two to three times per day, and especially after every bath or shower while the skin is still damp. Lukewarm baths only — hot water dries the skin further and can trigger Raynaud’s rebound. Use mild non-soap cleansers. Avoid alcohol-based products, harsh exfoliants, and any abrasive scrubs. Topical retinoids and harsh acids are off-limits unless directed by your rheumatologist or dermatologist.

Joint Contractures & Mobility Loss

As skin tightens, the small joints of the toes lose extension and flexion. Hammertoe and claw-toe deformities become rigid rather than flexible, the metatarsophalangeal joints stiffen, and ankle dorsiflexion can be reduced. The result is a high-pressure forefoot, fixed flexion of the toes, callus and ulceration over knuckles, and a progressively shorter, more shuffling gait. Roughly 40 to 60% of scleroderma patients have measurable joint contractures of the foot at 5 years from diagnosis.

Conservative management starts early. Daily passive range-of-motion exercises preserve mobility — one minute per joint, twice daily, gently. Physical therapy with a hand-therapist mindset (slow, sustained, low-load stretching) outperforms bursts of aggressive stretching. Custom orthotics with toe crests, metatarsal pads, and accommodative offloading reduce pressure points. Surgery is reserved for cases of refractory ulceration or severe pain, given that wound healing is impaired and surgery carries a high complication rate in this population.

Peripheral Neuropathy in Scleroderma

Peripheral neuropathy in scleroderma is underrecognized but documented in 10 to 30% of patients on careful neurologic exam. Mechanisms include vasculopathy (vascular damage to nerve blood supply), direct nerve compression from sclerotic skin (entrapments at the tarsal tunnel and Morton’s neuroma sites are increased), and mononeuritis multiplex from associated overlap syndromes. Symptoms range from mild numbness to severe burning and dysesthesia. Many of these patients also have mild small-fiber neuropathy not detected on routine NCS.

Workup is the same as any other neuropathy: B12 with methylmalonic acid, A1C, TSH, BMP, sometimes EMG/NCS. Read our full breakdown of peripheral neuropathy foot causes for the complete differential. Pharmacologic management includes gabapentinoids (gabapentin or pregabalin), duloxetine, or topical capsaicin or lidocaine. Always pair this with optimization of underlying scleroderma vasculopathy.

Vascular Disease & Critical Ischemia

Scleroderma is a small-vessel vasculopathy at heart, and the digital arteries are among the most affected. We watch for the transition from intermittent Raynaud’s to chronic critical ischemia: persistent rest pain in the toes, color that does not return on rewarming, dusky or blackened tips, and non-healing ulcers. This is a vascular emergency. The workup includes laser Doppler digital flow studies, transcutaneous oximetry, vascular MRI/MRA, and occasionally angiography. Treatment escalates from oral vasodilators to IV iloprost prostacyclin infusions to digital sympathectomy in selected cases.

In our clinic, every scleroderma patient gets a baseline pulse exam, capillary refill check, and toe-pressure measurement at the first visit, with rechecks every 6 months. Patients with documented digital ischemia are co-managed with vascular medicine. Smoking cessation is non-negotiable — one cigarette can trigger an ischemic attack, and the lifetime risk of digital amputation rises steeply with continued tobacco use.

How a Podiatrist Evaluates Scleroderma Feet (8-Step Visit)

The first scleroderma foot visit in our clinic is a 45-minute structured exam. We document everything because comparison over months is what catches early ulceration before it becomes catastrophic. The eight-step protocol is the same one we use for every patient we co-manage with rheumatology.

1. History & medication review. Date of diagnosis, subtype, autoantibody panel, current rheum medications, vasodilators, smoking history, prior ulcers, hospitalizations, and any internal organ involvement.
2. Inspection. Skin texture, sclerodactyly grade, calcinosis nodules, telangiectasias, pitting scars, ulcer locations, nail changes, hair growth, color and temperature.
3. Vascular exam. Dorsalis pedis and posterior tibial pulses, capillary refill at each toe, Allen’s test, toe-brachial index, transcutaneous oximetry when available.
4. Neurologic exam. 10-g monofilament at 10 sites per foot, vibration with 128-Hz fork, deep tendon reflexes, proprioception, light touch, and sharp/dull discrimination.
5. Joint & ROM. Ankle dorsiflexion, MTP and IPJ range, presence of contractures, hammertoe rigidity, hindfoot alignment.
6. Pressure analysis. Pedobarograph or in-shoe pressure mapping when ulcers are recurrent or calcinosis is suspected under the metatarsal heads.
7. Photographic documentation. Standardized photos of every ulcer, calcinosis nodule, and skin lesion at every visit for objective tracking.
8. Plan. Wound care orders, footwear and orthotic prescription, daily routine, education, follow-up at 4–6 weeks (more often if active ulcer), red-flag handout for after-hours.

Daily Foot-Care Protocol

The single most important intervention in scleroderma feet is the daily routine the patient does at home. Skip a day, miss a fissure, and an ulcer is born. We give every scleroderma patient a printed copy of the protocol below. It takes about 8 minutes a day and prevents most catastrophic complications.

• Daily inspection. Look at the bottom of every toe, between every toe, the heel, and the dorsum. A handheld mirror works for the soles. Photograph anything new.
• Daily moisturization. Thick fragrance-free emollient twice daily, applied to damp skin after a lukewarm shower. Avoid between-toe spaces (maceration risk).
• Daily warming. Heated socks, glove liners on the feet (yes, really), warm-water foot soaks at body temperature only (never hot), heated foot warmers indoors in winter.
• Nail care. Cut straight across, never round corners, file rough edges. Have a podiatrist trim if you cannot see your feet, have thick mycotic nails, or have any ulcer.
• Pressure relief. Wear protective socks and supportive insoles every step you take. Never barefoot, never around the house in slippers without grippy soles.
• Wound vigilance. Any new redness, warmth, fluid, smell, or pain that is disproportionate — call us same-day. Do not wait until the next routine visit.

Medical & Surgical Treatment

Treatment of scleroderma feet is multidisciplinary. Rheumatology manages the systemic disease and Raynaud’s pharmacotherapy. Vascular medicine manages critical ischemia. Podiatry manages the daily foot status: ulcer care, debridement, off-loading, footwear, infection surveillance, and surgical decisions. Dermatology often co-manages calcinosis. Pain management, physical therapy, and occupational therapy round out the team.

• Calcium-channel blockers. Nifedipine ER 30–120 mg/day — first-line for Raynaud’s.
• PDE-5 inhibitors. Sildenafil or tadalafil, especially when calcium-channel blockers are insufficient.
• Endothelin-receptor antagonists. Bosentan or macitentan to prevent recurrent digital ulcers.
• Prostacyclin infusions. IV iloprost or epoprostenol for severe ischemia or refractory ulceration.
• Topical nitroglycerin. 2% ointment to specific digits for vasospasm rescue.
• Botulinum toxin injections. Digital sympathetic blockade for severe Raynaud’s, off-label.
• Surgical options. Calcinosis curettage, digital sympathectomy, hammertoe release for ulcerated digits, partial or full digital amputation when ischemia is irreversible.

Footwear, Orthotics & Mobility

Footwear is medicine in scleroderma. The right shoe accommodates contractures, off-loads calcinosis, prevents ulceration, and warms the foot. The wrong shoe causes ulcers within weeks. We prescribe extra-depth, soft-leather shoes with a wide toe box, removable insole, and rocker-bottom sole for patients with limited toe motion. Patients with active ulcers need offloading boots or post-op shoes during healing. Severe deformity warrants custom-molded shoes.

Insoles should be soft accommodative, not corrective. We start with a quality OTC insole — PowerStep Pinnacle Maxx works for many mild cases — and step up to custom multi-density orthotics with metatarsal pads, calcinosis cutouts, and toe crests when needed. As an Amazon Associate, we earn from qualifying purchases. For Raynaud’s, heated socks (rechargeable battery type) are far better than ordinary thick socks at maintaining warmth across long days. Indoor slippers should always have rubber soles to prevent slipping — falls in scleroderma patients with thin soft tissue cause stubborn ulcers over the heel and lateral foot.

The #1 Mistake Patients Make

The most common mistake we see is delaying evaluation of a small ulcer or color change because patients are tired of medical appointments. Scleroderma patients see rheumatology, primary care, dermatology, GI, pulmonology, and vascular medicine on a regular basis — and the foot often becomes the “next visit” problem. We have seen too many small toe-tip ulcers turn into deep, infected, ischemic wounds that required amputation because the patient waited 4 weeks to call. If anything new shows up on your foot, call within 24 hours.

The second most common mistake is using over-the-counter callus removers, salicylic-acid pads, or aggressive pumice. Scleroderma skin is paper-thin in places, and these products cause iatrogenic ulcers. The third is wearing fashion shoes for short events — even one hour in a narrow shoe can create a pressure ulcer that takes 8 weeks to heal. The fourth is continuing to smoke. We will not be able to keep your toes if you continue to smoke.

Frequently Asked Questions

How does scleroderma cause foot pain?

Scleroderma causes foot pain through multiple mechanisms simultaneously: ischemic pain from Raynaud’s and digital vasospasm, ulcer pain at toe tips and pressure points, calcinosis nodule pain, joint contracture pain from rigid sclerotic skin, and neuropathic pain from small-fiber and entrapment neuropathy. Most scleroderma patients have at least two of these mechanisms operating at once, which is why pain control often requires more than one medication.

Can scleroderma cause toe amputation?

Yes. Roughly 5% of patients with severe digital vasculopathy require digital amputation at some point. Causes include refractory ischemic ulceration, deep infection (osteomyelitis), and irreversible gangrene. The risk rises sharply with smoking, untreated Raynaud’s, recurrent ulcers, and delayed evaluation of warning signs. Modern multimodal therapy — vasodilators, ulcer prevention, and prostacyclin infusions — has substantially lowered amputation rates.

What is the best moisturizer for scleroderma feet?

Thick, fragrance-free, lanolin- or petrolatum-based emollients are the standard. CeraVe Healing Ointment, Eucerin Original, and Aquaphor are reliable choices. Apply twice daily to damp skin after a lukewarm shower. Avoid alcohol, fragrance, retinoids, and exfoliating acids on scleroderma skin. Do not apply between toes — trapped moisture there causes maceration and infection. Severely dry heels may benefit from a urea-based cream (10–20%) once daily.

Should I see a podiatrist or rheumatologist for scleroderma feet?

Both. Rheumatology manages the systemic disease and prescribes vasodilator medications. A podiatrist manages the day-to-day foot status: ulcer care, off-loading, footwear, surveillance, and surgical decisions. Patients with active ulcers should see a podiatrist at least every 4–6 weeks, and quicker if anything new appears. Patients without active ulcers should still have a podiatry visit at least every 3–6 months for surveillance.

Can custom orthotics help scleroderma feet?

Yes — in many cases custom accommodative orthotics are the single most useful intervention for preventing ulceration. They redistribute pressure away from calcinosis nodules, hammertoe knuckles, prominent metatarsal heads, and bony heels. They are softer and more accommodative than the corrective orthotics used in mechanical foot pain. Insurance often covers them under diabetic-equivalent provisions or Medicare therapeutic shoe programs in qualifying patients.

How quickly do scleroderma foot ulcers heal?

Healing time depends on ulcer depth, location, infection, vascular status, and underlying skin tension. Uncomplicated superficial ulcers may close in 6 to 12 weeks with good care. Deep ischemic ulcers can take 6 months or more, and a fraction never close. Treatment optimization — vasodilators, off-loading, and infection control — cuts healing time substantially. Persistent non-healing after 12 weeks should trigger reassessment of vascular status and possible IV prostacyclin therapy.

The Bottom Line

Scleroderma feet are fragile and prone to ulcers, contractures, and ischemia, but the right daily protocol prevents most major complications. Strict cold avoidance, daily moisturization, daily inspection, and same-day evaluation of any new ulcer or color change are the four habits that keep scleroderma patients walking and intact for decades. Partner with a podiatrist who knows scleroderma. Do not wait.

Sources

1. Hughes M, Allanore Y, Chung L, et al. Raynaud phenomenon and digital ulcers in systemic sclerosis. Nat Rev Rheumatol. 2020;16(4):208–221.
2. Mihai C, Landewé R, van der Heijde D, et al. Digital ulcers predict a worse disease course in patients with systemic sclerosis. Ann Rheum Dis. 2016;75(4):681–686.
3. Korn JH, Mayes M, Matucci Cerinic M, et al. Digital ulcers in systemic sclerosis: prevention by treatment with bosentan, an oral endothelin receptor antagonist. Arthritis Rheum. 2004;50(12):3985–3993.
4. Steen V, Denton CP, Pope JE, Matucci-Cerinic M. Digital ulcers: overt vascular disease in systemic sclerosis. Rheumatology (Oxford). 2009;48(Suppl 3):iii19–iii24.
5. Valentini G, Riccardi A, Vettori S, et al. Scleroderma neuropathy: clinical and instrumental findings. Clin Exp Rheumatol. 2018;36 Suppl 113(4):112–116.

What is Foot pain?

Foot pain is a common foot/ankle condition that affects mobility and quality of life. Understanding the underlying cause is the first step in successful treatment. Our podiatrists at Balance Foot & Ankle perform a hands-on biomechanical exam, review your activity history, and use diagnostic imaging when appropriate to identify the root cause—not just treat the symptom. Many patients have been told to “rest and ice” without a deeper diagnostic workup; our approach is different.

Symptoms and warning signs

Common signs of foot pain include pain that worsens with activity, morning stiffness, swelling, tenderness when palpated, and difficulty bearing weight. If you experience sudden severe pain, inability to walk, visible deformity, numbness or color change, contact our office the same day or visit urgent care—these can signal a more serious injury such as a fracture, tendon rupture, or vascular compromise. Diabetics with any foot wound should seek same-day care.

Conservative treatment options

Most cases of foot pain respond to non-surgical care: structured rest, supportive footwear changes, custom orthotics, targeted stretching and strengthening protocols, anti-inflammatory medications when medically appropriate, and in-office procedures such as ultrasound-guided injections. We also offer advanced therapies including MLS laser therapy, EPAT/shockwave, regenerative injections, and image-guided procedures. Treatment is sequenced from least invasive to most invasive, and we explain the rationale at every step.

When is surgery considered?

Surgery is reserved for cases that fail 3-6 months of well-structured conservative care, when there is structural pathology (severe deformity, complete tear, advanced arthritis), or when imaging shows damage that will not heal without intervention. Our surgeons have performed 3,000+ foot and ankle procedures and prioritize minimally-invasive techniques whenever appropriate. We discuss recovery timelines, return-to-activity milestones, and realistic outcome expectations before any procedure is scheduled.

Recovery timeline and prevention

Recovery from foot pain varies based on severity and chosen treatment path. Conservative cases often improve within 4-8 weeks with consistent adherence to the protocol. Post-procedural recovery may range from a few days (in-office procedures) to several months (reconstructive surgery). Long-term prevention involves footwear assessment, activity modification, structured strengthening, and regular check-ins with your podiatrist if you have a history of recurrence. We provide written home-exercise plans and digital follow-up support.

In-Office Treatment at Balance Foot & Ankle

If home treatment isn’t providing relief for your foot and ankle conditions, our podiatry team at Balance Foot & Ankle can help with same-day evaluations and advanced in-office care.